000538 云南白药
已收盘 12-15 15:00:00
资讯
新帖
简况
云南白药集团连续三年荣获上市公司董办最佳实践
云南白药官微 · 12-07
云南白药集团连续三年荣获上市公司董办最佳实践
云南白药斩获CGMA“年度最佳管理会计实践”大奖，彰显行业标杆实力
云南白药官微 · 12-02
云南白药斩获CGMA“年度最佳管理会计实践”大奖，彰显行业标杆实力
云南白药新注册《小分子和蛋白质具体相互作用预测工具V1.0》项目的软件著作权
证券之星 · 11-15
云南白药新注册《小分子和蛋白质具体相互作用预测工具V1.0》项目的软件著作权
云南白药新注册《小分子过敏反应风险预测工具V1.0》项目的软件著作权
证券之星 · 11-12
云南白药新注册《小分子过敏反应风险预测工具V1.0》项目的软件著作权
云南白药最新公告：选举张文学为董事长
证券之星 · 11-10
云南白药最新公告：选举张文学为董事长
每周股票复盘：云南白药（000538）Q3净利增0.55%，股东户数增3.52%
证券之星 · 11-02
每周股票复盘：云南白药（000538）Q3净利增0.55%，股东户数增3.52%
云南白药（000538）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 11-01
云南白药（000538）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
云南白药(000538.SZ)发布前三季度业绩，归母净利润47.77亿元，增长10.41%
智通财经 · 10-30
云南白药(000538.SZ)发布前三季度业绩，归母净利润47.77亿元，增长10.41%
云南白药（000538）披露拟取消监事会并修订公司章程议案，10月27日股价上涨0.2%
证券之星 · 10-27
云南白药（000538）披露拟取消监事会并修订公司章程议案，10月27日股价上涨0.2%
每周股票复盘：云南白药（000538）新华都发行20亿可交换债
证券之星 · 10-26
每周股票复盘：云南白药（000538）新华都发行20亿可交换债
云南白药（000538）披露持股5％以上股东非公开发行可交换公司债券发行完成公告，10月23日股价上涨0.21%
证券之星 · 10-23
云南白药（000538）披露持股5％以上股东非公开发行可交换公司债券发行完成公告，10月23日股价上涨0.21%
云南白药：云南白药胶囊常用于跌打损伤、瘀血肿痛等
证券日报 · 09-30
云南白药：云南白药胶囊常用于跌打损伤、瘀血肿痛等
云南白药（000538）披露持股5％以上股东非公开发行可交换公司债券对持有的部分公司股票办理完成担保及信托登记的公告，9月29日股价上涨0.44%
证券之星 · 09-29
云南白药（000538）披露持股5％以上股东非公开发行可交换公司债券对持有的部分公司股票办理完成担保及信托登记的公告，9月29日股价上涨0.44%
云南白药：痛舒胶囊获临床试验伦理批件
证券之星 · 09-29
云南白药：痛舒胶囊获临床试验伦理批件
云南白药：支付职工现金增加因员工人数增长及人才引进
证券之星 · 09-29
云南白药：支付职工现金增加因员工人数增长及人才引进
云南白药：首批泰国生产牙膏已海外销售
证券之星 · 09-29
云南白药：首批泰国生产牙膏已海外销售
每周股票复盘：云南白药（000538）拟每10股派10.19元
证券之星 · 09-21
每周股票复盘：云南白药（000538）拟每10股派10.19元
云南白药（000538）披露2025年半年度报告，9月18日股价下跌0.81%
证券之星 · 09-18
云南白药（000538）披露2025年半年度报告，9月18日股价下跌0.81%
研报掘金丨东方证券：维持云南白药“买入”评级，目标价65.78元
格隆汇 · 09-12
研报掘金丨东方证券：维持云南白药“买入”评级，目标价65.78元
太平洋：给予云南白药买入评级
证券之星 · 09-11
太平洋：给予云南白药买入评级
暂无数据
公司概况
公司名称：
云南白药集团股份有限公司
所属行业：
医药制造业
上市日期：
1993-12-15
主营业务：
云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品、批发零售、农产品。2025年上半年，云南白药第16年上榜财富中文网发布的《财富中国500强排行榜》，位列第357位；入选美国《制药经理人》杂志《全球制药企业50强排行榜》，位列第33位。
发行价格：
3.38
{"stockData":{"symbol":"000538","market":"SZ","secType":"STK","nameCN":"云南白药","latestPrice":55.86,"timestamp":1765782204000,"preClose":55.83,"halted":0,"volume":4454191,"delay":0,"changeRate":0.0005,"floatShares":1773000000,"shares":1784000000,"eps":2.9143,"marketStatus":"已收盘","change":0.03,"latestTime":"12-15 15:00:00","open":55.8,"high":55.97,"low":55.63,"amount":249000000,"amplitude":0.0061,"askPrice":55.87,"askSize":14,"bidPrice":55.86,"bidSize":21,"shortable":0,"etf":0,"ttmEps":2.9143,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":5,"adr":0,"adjPreClose":55.83,"symbolType":"stock","openAndCloseTimeList":[[1765762200000,1765769400000],[1765774800000,1765782000000]],"highLimit":61.41,"lowLimit":50.25,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1784262603,"isCdr":false,"pbRate":2.51,"roa":"--","peRate":19.167553,"roe":"11.92%","epsLYR":2.66,"committee":0.167756,"marketValue":99669000000,"turnoverRate":0.0025,"status":0,"floatMarketCap":99028000000},"requestUrl":"/m/hq/s/000538/tweets","defaultTab":"tweets","newsList":[{"id":"2589870677","title":"云南白药集团连续三年荣获上市公司董办最佳实践","url":"https://stock-news.laohu8.com/highlight/detail?id=2589870677","media":"云南白药官微","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589870677?lang=zh_cn&edition=full","pubTime":"2025-12-07 20:37","pubTimestamp":1765111020,"startTime":"0","endTime":"0","summary":"12月3日，中国上市公司协会发布“上市公司董办最佳实践案例征集活动”结果，云南白药集团荣获2025上市公司董事会办公室最佳实践，实现连续三年荣获该项殊荣。2025上市公司董办最佳实践案例征集活动于今年10月启动，经初审、专家委员会评审、诚信核查等环节，最终评出最佳实践案例344家，优秀实践案例316家。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-07/doc-infzyswc3252206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0012","BK0028","BK0187","BK0164","BK0188","BK0239","LU1960683339.HKD","LU1807302812.USD","LU1993786604.SGD","BK0196","000538","BK0175"],"gpt_icon":0},{"id":"2588057037","title":"云南白药斩获CGMA“年度最佳管理会计实践”大奖，彰显行业标杆实力","url":"https://stock-news.laohu8.com/highlight/detail?id=2588057037","media":"云南白药官微","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588057037?lang=zh_cn&edition=full","pubTime":"2025-12-02 18:15","pubTimestamp":1764670500,"startTime":"0","endTime":"0","summary":"凭借在管理会计领域的深度创新与卓越实践，云南白药集团股份有限公司成功斩获“年度最佳管理会计实践”奖项，这一荣誉不仅是国际权威机构对云南白药集团财经管理工作的高度认可，更标志着云南白药在数字化转型与业财融合领域的实践已跻身行业前列。云南白药集团从众多实力强劲的参评企业中脱颖而出，充分印证了云南白药集团管理会计实践的硬核实力与行业示范价值。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-02/doc-infzmifc1000338.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1807302812.USD","LU1993786604.SGD","BK0164","BK0175","BK0012","000538","LU1960683339.HKD","BK0188","BK0239","BK0028","BK0196","BK0187"],"gpt_icon":0},{"id":"2583162683","title":"云南白药新注册《小分子和蛋白质具体相互作用预测工具V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2583162683","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583162683?lang=zh_cn&edition=full","pubTime":"2025-11-15 00:30","pubTimestamp":1763137838,"startTime":"0","endTime":"0","summary":"证券之星消息，近日云南白药（000538）新注册了《小分子和蛋白质具体相互作用预测工具V1.0》项目的软件著作权。今年以来云南白药新注册软件著作权2个。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了1.56亿元，同比增5.31%。通过天眼查大数据分析，云南白药集团股份有限公司共对外投资了35家企业，参与招投标项目20547次；财产线索方面有商标信息3254条，专利信息546条，著作权信息77条；此外企业还拥有行政许可1240个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111500000188.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1960683339.HKD","BK0188","BK0239","BK0028","BK0012","LU1993786604.SGD","BK0187","BK0175","BK0196","LU1807302812.USD","BK0164","000538"],"gpt_icon":0},{"id":"2582764396","title":"云南白药新注册《小分子过敏反应风险预测工具V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2582764396","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582764396?lang=zh_cn&edition=full","pubTime":"2025-11-12 01:51","pubTimestamp":1762883472,"startTime":"0","endTime":"0","summary":"证券之星消息，近日云南白药（000538）新注册了《小分子过敏反应风险预测工具V1.0》项目的软件著作权。今年以来云南白药新注册软件著作权1个。结合公司2025年中报财务数据，今年上半年公司在研发方面投入了1.56亿元，同比增5.31%。通过天眼查大数据分析，云南白药集团股份有限公司共对外投资了35家企业，参与招投标项目20547次；财产线索方面有商标信息3254条，专利信息546条，著作权信息77条；此外企业还拥有行政许可1240个。数据来源：天眼查APP以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111200000975.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1960683339.HKD","BK0187","BK0196","LU1807302812.USD","BK0175","BK0164","LU1993786604.SGD","BK0012","BK0028","000538","BK0188","BK0239"],"gpt_icon":0},{"id":"2582820412","title":"云南白药最新公告：选举张文学为董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=2582820412","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582820412?lang=zh_cn&edition=full","pubTime":"2025-11-10 19:20","pubTimestamp":1762773619,"startTime":"0","endTime":"0","summary":"云南白药(000538.SZ)公告称，公司第十一届董事会2025年第一次会议于11月10日召开，选举张文学为董事长，董明为副董事长，任期三年。同时，会议选举产生了各专门委员会委员及主任委员。第十一届董事会成员包括非独立董事张文学、董明、郭昕、游光辉、谢云山、上官常川、李科，以及独立董事刘国恩、纳超洪、胡明星、曹仰锋。职工董事杨帆的公示期已截止，将正式履职。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000028488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","BK0188","BK0239","BK0164","LU1960683339.HKD","LU1993786604.SGD","LU1807302812.USD","BK0012","BK0175","BK0028","BK0196","BK0187"],"gpt_icon":0},{"id":"2580473659","title":"每周股票复盘：云南白药（000538）Q3净利增0.55%，股东户数增3.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580473659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580473659?lang=zh_cn&edition=full","pubTime":"2025-11-02 02:06","pubTimestamp":1762020372,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘，云南白药报收于56.66元，较上周的56.36元上涨0.53%。股本股东变化截至2025年9月30日，云南白药股东户数为16.68万户，较6月30日增加5676户，增幅3.52%。业绩披露要点云南白药2025年三季报显示，前三季度主营收入306.54亿元，同比上升2.47%；归母净利润47.77亿元，同比上升10.41%；扣非净利润45.5亿元，同比上升6.68%。本次质押后，新华都及其一致行动人累计质押股份14850万股，占其合计持股33.03%，占公司总股本8.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200000301.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0187","BK0164","BK0196","BK0028","LU1960683339.HKD","000538","BK0188","LU1993786604.SGD","LU1807302812.USD","BK0012","BK0239"],"gpt_icon":0},{"id":"2580295412","title":"云南白药（000538）2025年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2580295412","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580295412?lang=zh_cn&edition=full","pubTime":"2025-11-01 06:35","pubTimestamp":1761950103,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期云南白药发布2025年三季报。截至本报告期末，公司营业总收入306.54亿元，同比上升2.47%，归母净利润47.77亿元，同比上升10.41%。本报告期云南白药盈利能力上升，毛利率同比增幅5.84%，净利率同比增幅7.94%。报告期内，实现营业收入212.57亿元，较上年同期增长3.92%；实现归母净利润36.33亿元，较上年同期的31.89亿元同比增长13.93%，创同期历史新高；扣非归母净利润34.61亿元，较上年同期的31.35亿元同比增长10.40%，创同期历史新高。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110100007147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"gpt_icon":0},{"id":"2579487121","title":"云南白药(000538.SZ)发布前三季度业绩，归母净利润47.77亿元，增长10.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579487121","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579487121?lang=zh_cn&edition=full","pubTime":"2025-10-30 23:42","pubTimestamp":1761838924,"startTime":"0","endTime":"0","summary":"智通财经APP讯，云南白药(000538.SZ)发布2025年三季度报告，该公司前三季度营业收入为306.54亿元，同比增长2.47%。归属于上市公司股东的净利润为47.77亿元，同比增长10.41%。归属于上市公司股东的扣除非经常性损益的净利润为45.5亿元，同比增长6.68%。基本每股收益为2.68元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"云南白药(000538.SZ)发布前三季度业绩，归母净利润47.77亿元，增长10.41%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000538"],"gpt_icon":0},{"id":"2578161649","title":"云南白药（000538）披露拟取消监事会并修订公司章程议案，10月27日股价上涨0.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578161649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578161649?lang=zh_cn&edition=full","pubTime":"2025-10-27 17:17","pubTimestamp":1761556673,"startTime":"0","endTime":"0","summary":"截至2025年10月27日收盘，云南白药报收于56.47元，较前一交易日上涨0.2%，最新总市值为1007.57亿元。公司近日发布公告称，将于2025年11月10日召开2025年第二次临时股东大会，审议包括关于取消监事会并修订《公司章程》的议案、修订《股东大会议事规则》和《董事会议事规则》的议案，以及选举第十一届董事会非独立董事和独立董事的累积投票议案。上述议案已获第十届董事会2025年第六次会议审议通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700023736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0012","LU1993786604.SGD","BK0028","BK0175","LU1807302812.USD","BK0196","LU1960683339.HKD","000538","BK0164","BK0188","BK0187"],"gpt_icon":0},{"id":"2578050400","title":"每周股票复盘：云南白药（000538）新华都发行20亿可交换债","url":"https://stock-news.laohu8.com/highlight/detail?id=2578050400","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578050400?lang=zh_cn&edition=full","pubTime":"2025-10-26 02:46","pubTimestamp":1761417972,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，云南白药报收于56.36元，较上周的57.06元下跌1.23%。本周，云南白药10月20日盘中最高价报57.34元。公司公告汇总关于持股5％以上股东非公开发行可交换公司债券发行完成的公告云南白药集团股份有限公司于2025年10月23日收到持股5%以上股东新华都实业集团股份有限公司通知，其非公开发行的可交换公司债券已完成发行。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0210","BK0170","BK0070","BK0187","BK0239","BK0175","BK0217","BK0028","BK0012","002264","000538","LU1807302812.USD","BK0209","BK0188","BK0102","LU1993786604.SGD","BK0137","LU1960683339.HKD","BK0196","BK0093","BK0164"],"gpt_icon":0},{"id":"2577583888","title":"云南白药（000538）披露持股5％以上股东非公开发行可交换公司债券发行完成公告，10月23日股价上涨0.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577583888","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577583888?lang=zh_cn&edition=full","pubTime":"2025-10-23 22:10","pubTimestamp":1761228646,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，云南白药报收于56.57元，较前一交易日上涨0.21%，最新总市值为1009.36亿元。该股当日开盘56.38元，最高56.57元，最低56.21元，成交额达3.13亿元，换手率为0.31%。根据近日发布的公告，云南白药集团股份有限公司于2025年10月23日收到持股5%以上股东新华都实业集团股份有限公司的书面通知，其非公开发行的可交换公司债券已完成发行。公司将继续履行相关信息披露义务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102300037650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0239","000538","BK0164","BK0187","BK0028","LU1993786604.SGD","BK0196","LU1960683339.HKD","BK0012","BK0188","LU1807302812.USD"],"gpt_icon":0},{"id":"2571465073","title":"云南白药：云南白药胶囊常用于跌打损伤、瘀血肿痛等","url":"https://stock-news.laohu8.com/highlight/detail?id=2571465073","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571465073?lang=zh_cn&edition=full","pubTime":"2025-09-30 17:36","pubTimestamp":1759224960,"startTime":"0","endTime":"0","summary":"证券日报网讯云南白药9月30日在互动平台回答投资者提问时表示，云南白药胶囊常用于跌打损伤、瘀血肿痛，各种出血，疮疡肿毒及软组织挫伤，闭合性骨折，及皮肤感染性疾病。请严格按照说明书或遵医嘱使用。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-30/doc-infshnvn8017696.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-30/doc-infshnvn8017696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0187","BK0012","BK0175","BK0188","BK0164","BK0196","000538","BK0028","BK0239"],"gpt_icon":0},{"id":"2571332896","title":"云南白药（000538）披露持股5％以上股东非公开发行可交换公司债券对持有的部分公司股票办理完成担保及信托登记的公告，9月29日股价上涨0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571332896","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571332896?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:12","pubTimestamp":1759155138,"startTime":"0","endTime":"0","summary":"截至2025年9月29日收盘，云南白药报收于57.36元，较前一交易日上涨0.44%，最新总市值为1023.45亿元。该担保及信托登记手续已办理完毕，占新华都所持股份比例的12.85%，占公司总股本的3.14%。截至公告日，新华都及其一致行动人合计持股449,624,311股，累计质押、担保及信托登记股份数量为131,000,000股，占其持股总数的29.14%，占公司总股本的7.34%。表决权行使将征求新华都意见。公司将继续履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900035241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0239","BK0188","BK0196","BK0028","BK0164","000538","BK0187","BK0175"],"gpt_icon":0},{"id":"2571538525","title":"云南白药：痛舒胶囊获临床试验伦理批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2571538525","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571538525?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:12","pubTimestamp":1759137130,"startTime":"0","endTime":"0","summary":"痛舒胶囊治疗骨关节炎引起的关节痛的有效性和安全性的随机、双盲、安慰剂对照临床试验获组长医院伦理批件，已完成医学研究登记备案。洛索洛芬钠凝胶贴膏项目获得临床试验通知书，同步开展制剂相关评价工作。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900022448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0187","BK0164","000538","BK0028","BK0239","BK0175","BK0012","BK0196"],"gpt_icon":0},{"id":"2571853713","title":"云南白药：支付职工现金增加因员工人数增长及人才引进","url":"https://stock-news.laohu8.com/highlight/detail?id=2571853713","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571853713?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:06","pubTimestamp":1759136768,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药09月29日在投资者关系平台上答复投资者关心的问题。请问公司现金流量表中支付给职工以及为职工支付的现金21年开始突然大增，且自21年之后逐年上升，由20年的15亿到24年达到了27.8亿，即该支出24年比20年增长了85%！公司自2020年至2024年，扣非归母净利润由28.99亿增长到45.23亿，保持健康可持续增长。近年来，公司员工人数增加、引进中高层次人才等导致支付给职工以及为职工支付的现金有所增加。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900022061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0175","BK0188","000538","BK0164","BK0187","BK0028","BK0239","BK0196","BK0012"],"gpt_icon":0},{"id":"2571383049","title":"云南白药：首批泰国生产牙膏已海外销售","url":"https://stock-news.laohu8.com/highlight/detail?id=2571383049","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571383049?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:03","pubTimestamp":1759136592,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药09月29日在投资者关系平台上答复投资者关心的问题。公司部分大健康产品已通过本地注册销售和跨境电商等多种形式实现海外销售，市场覆盖北美洲、亚洲的主要地区及部分欧洲和中东地区。公司下属子公司云白国际有限公司近日发布公告，由云白国际安排于泰国生产的以“云南白药”为品牌名称的首批牙膏产品已由云白国际在中国内地以外销售。2025年上半年，公司国外收入2.3亿，同比增长7.9%，谢谢！","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900021924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0028","BK0196","000538","BK0187","BK0175","BK0239","BK0164","BK0012"],"gpt_icon":0},{"id":"2569243994","title":"每周股票复盘：云南白药（000538）拟每10股派10.19元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569243994","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569243994?lang=zh_cn&edition=full","pubTime":"2025-09-21 02:00","pubTimestamp":1758391240,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，云南白药报收于58.48元，较上周的58.99元下跌0.86%。本周，云南白药9月17日盘中最高价报59.53元。本周关注点公司公告汇总：云南白药拟每10股派发现金红利10.19元（含税），股权登记日为2025年9月23日。业绩披露要点经董事会审议通过的利润分配预案为：以公司总股本1,784,262,603股为基数，向全体股东每10股派发现金红利10.19元（含税），不送红股，不以资本公积金转增股本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100000308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0028","BK0196","000538","BK0239","BK0012","BK0175","BK0188","BK0164"],"gpt_icon":0},{"id":"2568540528","title":"云南白药（000538）披露2025年半年度报告，9月18日股价下跌0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568540528","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568540528?lang=zh_cn&edition=full","pubTime":"2025-09-18 22:38","pubTimestamp":1758206302,"startTime":"0","endTime":"0","summary":"截至2025年9月18日收盘，云南白药报收于58.49元，较前一交易日下跌0.81%，最新总市值为1043.62亿元。近日，云南白药发布2025年中期报告摘要，公告显示，经董事会审议通过的利润分配预案为：以公司总股本1,784,262,603股为基数，向全体股东每10股派发现金红利10.19元（含税），不送红股，不以资本公积金转增股本。此外，报告期内公司新设子公司云南白药集团数字智能科技有限公司和PT YNBY Healthcare Indonesia，并已自设立当月起纳入合并范围。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091800037679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0239","BK0164","BK0175","BK0188","000538","BK0012","BK0187","BK0028"],"gpt_icon":0},{"id":"2566927467","title":"研报掘金丨东方证券：维持云南白药“买入”评级，目标价65.78元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566927467","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566927467?lang=zh_cn&edition=full","pubTime":"2025-09-12 17:25","pubTimestamp":1757669103,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0188","BK1564","BK0028","600958","03958","BK0183","BK1147","BK0196","000538","BK0187","BK0175","BK0276","BK0239","BK0164","BK0012"],"gpt_icon":0},{"id":"2566476936","title":"太平洋：给予云南白药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2566476936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566476936?lang=zh_cn&edition=full","pubTime":"2025-09-11 08:30","pubTimestamp":1757550638,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司谭紫媚,张懿近期对云南白药进行研究并发布了研究报告《云南白药：工业收入占比提升，核药管线临床顺利》，给予云南白药买入评级。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级4家，增持评级3家；过去90天内机构目标均价为73.14。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091100006282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","601099"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765804575419,"stockEarnings":[{"period":"1week","weight":-0.0018},{"period":"1month","weight":-0.0226},{"period":"3month","weight":-0.0366},{"period":"6month","weight":0.0058},{"period":"1year","weight":-0.0172},{"period":"ytd","weight":-0.0321}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"云南白药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"166806人(较上一季度增加3.52%)","perCapita":"10627股","listingDate":"1993-12-15","address":"云南省昆明市呈贡区云南白药街3686号","registeredCapital":"178426万元","survey":" 云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品、批发零售、农产品。2025年上半年，云南白药第16年上榜财富中文网发布的《财富中国500强排行榜》，位列第357位；入选美国《制药经理人》杂志《全球制药企业50强排行榜》，位列第33位。","listedPrice":3.38},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云南白药,000538,云南白药股票,云南白药股票老虎,云南白药股票老虎国际,云南白药行情,云南白药股票行情,云南白药股价,云南白药股市,云南白药股票价格,云南白药股票交易,云南白药股票购买,云南白药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}